4-(4-氰基苄基)-1,2,4-噻唑

4-(4-Cyanobenzyl)-1,2,4-triazole is an intermediate in the synthesis of Letrozole, an oral, non-steroidal, aromatase inhibitor generally used to treat breast cancer as a result of hormone response after surgery.